Mental Health Flashcards

1
Q

What are the main theories used to understand mental health disorders (and their causes, treatments & limitations)

A
  • Supernatural
  • Medical/biological
    cause: internal biological dysfunction
    treatment: target biological deficiencies e.g. medication
    limitations: extreme reductionism
  • Psychoanalytic
    cause: maladjustment from excessively/rigidly applied defence mechanisms i.e. repression, denial, projection, displacement, regression, sublimation
    treatment: gaining insight into unconscious processes e.g. dream analysis
    limitations: lacks empirical evidence (unfalsifiable), unreliable
  • Behavioural
    cause: all behaviour is shaped by learning history
    treatment: habituation to feared stimuli, extinguish old responses, reward systems
    limitations: no focus on cognition, fails to explain observed or indirect behaviour
  • Cognitive/Behavioural
    cause: maladjustment, negative core beliefs lead to automatic negative thoughts which shape behaviour
    treatment: cognitive challenging, behavioural experiments, exposure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the differences between the DSM and ICD

A

ICD - used in Europe, currently 10th edition

DSM - used in Australia/USA (English-speaking world), currently 5th edition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Outline the important advances of the DSM throughout history

A
  • Homosexuality removed (1973)
  • Generalised anxiety disorder added (1987)
  • Binge eating disorder added(2013)
  • Asperger’s reclassified (2013)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outline the benefits and limitations of diagnosis & the DSM5

A

Benefits of classification - identifying diagnostic categories can lead to specific treatment
Benefits of diagnosing - improved communication & understanding, reduced stigma

Limitations of classification & diagnosis - constantly increasing number of disorders (reification), extreme reductionism, harmful (limiting opportunities and self-beliefs), doesn’t explain comorbidity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the main diagnostic criteria and symptoms of depressive episodes vs. depressive disorder

A

Depressive episode
A. At least 5+ symptoms
affective symptoms: depressed mood, anhedonia
somatic symptoms: fatigue, sleep/appetite change
cognitive symptoms: feelings of guilt, lack of concentration
B. Clinically significant distress/impairment
C. Not attributed to substance use or another medical condition

Depressive disorder - single or recurring depressive episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe features of hypomanic, manic episodes & cyclothymia

A

Bipolar Disorder I (Manic episode)
A. at least 1 week abnormally elevated/expansive/irritable mood AND increased goal-directed behaviour

B. At least 3+ symptoms
inflated self-esteem/grandiosity, decreased need for sleep, rapid/ pressured sleep, flight of ideas/racing thoughts, distractibility, increase in goal-directed activity, excessive involvement in high risk activities

C. Mood disturbance causes marked impairment, requires hospitalisation to prevent self-harm, includes psychotic features

Bipolar Disorder II (Hypomanic) - same as BPI but to as lesser extent, no psychotic features & not severe enough to cause marked impairment/hospitalisation

Cyclothymia - chronic, less severe form of bipolar disorder, numerous cycles of hypomanic & depressive symptoms, but not severe enough to meet the criteria for a manic or major depressive episode, at least 2 years, no more than 2 months without symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Outline the epidemiology of bipolar disorder (POCC)

A

Prevalence - 1 in 50 Australians, men = women for BP1, women > men for BP2

Onset - emerges in late adolescence/early adulthood

Course - predominantly depressive, 10-20 year delay in seeking treatment

Comorbidity - 50% anxiety disorders, 39% substance misuse, 25% attempt suicide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Outline the aetiological factors of bipolar disorder (GBEP)

A

Genetic - 10% chance if parent has it, high heritability

Biological - neurobiological disorder as the 3 “reward-system NT’s (serotonin, dopamine, noradrenaline) malfunction

Environmental - manic & depressive episodes likely follow a change in environment (e.g. manic - disrupted routine/sleep cycles, excessive focus on goal attainment… depressive - low social support/self-esteem)

Psychological - negative core beliefs, perfectionism & sociotrophy (extreme need for approval)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the difference between normal & abnormal anxiety

A

Both activate same 3 inter-related systems in response to a perceived threat (physical, cognitive, behavioural)

Normal anxiety - evolutionary value (survival & social stability)
Abnormal anxiety - overestimation of threat appraisal, deviant, distressing & dysfunctional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Outline the main diagnostic criteria for Social Anxiety Disorder

A

A. Marked fear of situations where social scrutiny may occur

B. Fear that one will be negatively evaluated based on their actions

C. Social situations almost always provoke anxiety/fear

D. Social situations are avoided or endured with intense anxiety/fear

E. Anxiety is disproportional to the actual threat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the epidemiology of Social Anxiety Disorder (POCC)

A

Prevalence - 1 in 12 Australians, lower rates in European & Asian countries as they are more collectivistic, men more likely to seek treatment (women in clinical samples < general population) -> signs of weakness

Onset - childhood/adolescence

Course - chronic without treatment but 60% recover after 5+ years without treatment, only 50% seek treatment

Comorbidity - other anxiety disorders, depression, substance use, avoidant personality disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the treatment for Social Anxiety Disorder

A
  • CBT: to reduce inflated threat appraisal
  • Psychoeducation: “anxiety is normal… threat appraisal… avoidance is a reinforcer”
  • Cognitive techniques: challenging & modifying unhelpful/inaccurate thoughts
  • Behavioural techniques: exposure therapy (flooding < systemic desensitisation), behavioural experiments
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Outline the main diagnostic criteria for schizophrenia

A

A. 2+ symptoms & at least 1 psychotic symptom for at least 1 month

B. Clinically significant distress/disturbances in functioning

C. Disturbances in functioning for > 6 months + at least 1 month of psychotic symptoms

D-F. Not better accounted for by: schizoaffective, substance use disorder, autism spectrum disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the core symptoms of schizophrenia

A

Positive symptoms - presence of problematic behaviour

  • psychotic symptoms (delusions, hallucinations, disorganised speech)
  • grossly disorganised/catatonic behaviour

Negative symptoms - absence of healthy behaviour

  • affective flattening (social withdrawal, anhedonia)
  • avolition (amotivation, apathy, self-neglect)
  • alogia (poverty of speech, poverty of content)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the epidemiology of schizophrenia (POC)

A

Prevalence - 1-2%, 3:2 male:female

Onset - late adolescence/early adulthood

Course - highly variable (normal behaviour between psychotic episodes), chronic condition (50% unable to work, homelessness, low income etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the aetiology of schizophrenia (GNN)

A

Genetic - higher risk with closer genetic similarity (e.g parents more likely than grandparents)

Neurochemical - dopamine hypothesis (treatment for Parkinson’s with dopamine induced psychotic symptoms, anti-dopaminergic medication was effective in 60% of patients with more impact on positive symptoms

Neuroanatomical - enlarged ventricles & loss of brain tissue in pre-frontal cortex in schizophrenic patients

17
Q

What are the prognostic features of schizophrenia

A

Early onset -> poorer outcomes

Early treatment -> better outcomes

18
Q

Describe the treatments used for schizophrenia

A

Medication - 60% of patients with positive symptoms respond, but high relapse rates & non-compliance (paranoia)

Psychological - targeted to the stage of illness, targeting specific deficits (e.g. social skills, medication compliance, stress management, family conflict, reducing delusions)

19
Q

Describe the diagnostic criteria & core symptoms of substance use disorders

A

A. 2+ symptoms for at least 12 months

Impaired control

  • using larger amounts than intended
  • persistent desire/unsuccessful attempts to cut back
  • excessive time obtaining/using/recovering from substances
  • craving

Social impairment

  • failure to meet obligations
  • social or interpersonal difficulties
  • social/occupational/recreational activities reduced/given up

Risky use

  • use in physically hazardous situations (e.g. driving)
  • persistence despite awareness of physical/psychological problems exacerbated by use

Pharmacological indicators

  • tolerance
  • withdrawal
20
Q

Describe the epidemiology of substance use disorders (PC)

A

Prevalence - 1 in 15 Australians (alcohol use disorder), 1 in 45 (any other substance use disorder), males > females

Comorbidity - 60% patients have a comorbid disorder, anxiety > depression > PTSD (due to overlapping genetic & environmental triggers)

21
Q

Describe the aetiology of substance use disorders (GBEP)

A

Genetic - strong poly-genetic component

Biological - dopamine hypothesis (speed of reward system activation determines effectiveness)

Environmental - family history, peer pressure, low parental monitoring, harsh disciplining approaches

Psychological - behavioural factors (classical/instrumental conditioning, cue elicited craving), cognitive factors (negative core beliefs & cognitive distortion)

22
Q

Describe the core treatment issues when treating substance use disorders

A
  1. No single treatment is effective
  2. Needs to be readily available & accessible
  3. Dual diagnosed patients need to have both disorders treated in an integrated fashion
  4. Recovery can be long term & require multiple episodes of treatment
23
Q

Describe the main medical and psychological interventions used to treat substance use disorders

A

Medical - detoxification (doesn’t target maintaining factors, relapse rates don’t change), pharmacological (antagonists & agonists)

Psychological - motivational interviewing (MI, used in contemplation stage), cognitive-behavioural therapy (CBT, challenging dysfunctional thoughts etc.)

24
Q

Describe the main types of psychotherapy

A
  1. Psychoanalysis (Sigmund Freud, ego, superego, id)
  2. Behaviour therapy (Skinner/Pavlov, based on conditioning)
  3. Cognitive therapy (Aaron Beck, identify/challenge dysfunctional cognitions
  4. MBSR, MBCT, ACT, DBT (mindfulness, values)
  5. CBT & 3rd wave CBT (more humanistic/spiritual)
  6. Mindfulness based approaches
25
Q

Outline the main factors to consider when assessing psychotherapy effectiveness

A

Delivery

Generic factors - little/no specific effect of different treatments (general counselling skills, client motivation)

Placebo effect